Techniques: Anti-galectin-3 (LGALS3) mAb-based PET imaging agent to diagnose thyroid cancer

Imaging

TECHNOLOGY: PET

A mAb-based PET imaging agent targeting LGALS3 could

Read the full 98 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE